Dialysis Solutions

05/01/2008 - "Some observational non-randomized trials have reported improved survival and a lower incidence of peritonitis in patients both with and without diabetes treated with these modern dialysis solutions. "
01/01/2022 - "We are the first group to demonstrate the predictive efficacy of peritoneal dialysate (PDE) NLR in distinguishing TB/NTM peritonitis from bacterial causes in the PD population. "
07/01/2011 - "Improved conventional method for the laboratory diagnosis of peritonitis from peritoneal dialysate in Sudan."
09/01/1998 - "In peritonitis, whether increased permeability results in improved dialysate levels remains to be defined."
02/01/1987 - "The efficacy of recovery of peritonitis-causing microorganisms from peritoneal dialysate fluid by using the Septi-Chek blood culture system (Roche Diagnostics, Div. "

01/01/2023 - "Cold dialysate decreased intradialytic hypotension with no significant improvement of the nutritional and inflammatory surrogates. "
02/01/1985 - "Cool dialysate reduced the frequency of symptomatic hypotension from 0.58 to 0.05 episodes per dialysis (P = less than 0.016). "
05/06/2017 - "The studies to date that have evaluated cooled dialysate are limited, however, data suggest that cooled dialysate improves hemodynamic tolerability of dialysis, minimizes hypotension and exerts a protective effect over major organs including the heart and brain. "
08/01/2002 - "However, formal clinical trials in which dialysate temperature is tailored to the body temperature of appropriately selected hypotension-prone patients are lacking. "
01/01/1984 - "Studies in a conscious, nonuremic dog model suggest that use of dialysate hyponatric to plasma tends to cause hypotension during dialytic ultrafiltration by accelerating the rate of contraction of plasma volume. "

09/01/2004 - "A dialysate Ca of 2.5 mEq/L may be used in patients with a high tendency to hypercalcemia. "
01/01/1996 - "Adequate control of plasma levels of iCa, P and PTH could be achieved with both lower Ca dialysates without either hypercalcemia or use of Al-containing P binders in the majority of patients. "
07/01/1994 - "It is concluded that the use of low Ca2+ dialysate corrects hypercalcemia in patients with PFD treated with high oral doses of CaCO3, and improves low turnover bone disease. "
01/01/2003 - "Seven patients were changed to low-Ca dialysate (1.0 mEq/L) secondary to hypercalcemia (Ca > 11.5 mg/dL) and severe secondary hyperparathyroidism. "
11/01/1997 - "In patients with hypercalcemia and elevated PTH levels, treatment with dialysate Ca concentrations below 1.25 mmol/L implied a considerable risk for the progression of secondary hyperparathyroidism. "

01/01/1996 - "This study describes an isocratic reversed phase high-performance liquid chromatographic method for the analysis of pyridinium crosslinks in serum, urine and dialysates obtained from patients with chronic renal failure on haemodialysis. "
09/01/2023 - "Even higher RR's are possible if the dialysate volume flow rate can be increased beyond 600 mL/min. ddHDF provides an opportunity for a step change increase in the level of extraction of both larger LMWP and PBUT in patients with end-stage kidney disease."
12/01/2022 - "The practice with dialysate low flow with the optimization of storage space, the simplification of the use of generators and the emmergence of telemonitoring tools increases the accessibility of this dialysis technique, so that we can hope in the coming years to be able to offer this dialysis modality to any patient with chronic renal failure requiring extra-renal purification. "
01/01/2022 - "The serum IS (P < .001) and pCS (P < .001) concentrations were far higher in patients with ESRD than those in healthy controls, whereas the daily total removal by urine and dialyzate was much lower for the former than that for the latter (P = .019 for IS, P = .016 for pCS). "
07/01/2019 - "Also contributory are patient-related factors such as the effect of the immunocompromised status of end-stage renal disease and the presence of intraperitoneal dialysate on the disruption of natural host defense mechanisms. "

01/01/2003 - "The results showed that OCT is stable in dialysis solution and that its intraperitoneal administration was effective for suppressing PTH in patients with secondary hyperparathyroidism."
09/01/2002 - "This suggests that low Ca(2+) dialysate may exaggerate the progression of secondary hyperparathyroidism."
11/01/1995 - "Recent approaches to prevent and treat secondary hyperparathyroidism in dialysis patients include decreasing dialysate Ca content from 1.75 to 1.5 mM or lower. "
01/01/2003 - "Seven patients were changed to low-Ca dialysate (1.0 mEq/L) secondary to hypercalcemia (Ca > 11.5 mg/dL) and severe secondary hyperparathyroidism. "
11/01/1997 - "In patients with hypercalcemia and elevated PTH levels, treatment with dialysate Ca concentrations below 1.25 mmol/L implied a considerable risk for the progression of secondary hyperparathyroidism. "